Ortivus AB (publ) (ORTI-B.ST) Research
Ortivus AB (publ), established in 1985 and based in Danderyd, Sweden, focuses on developing and commercializing medical technology solutions for the global healthcare sector. Their product lineup includes MobiMed Monitor, designed for tracking vital patient parameters like ECG, blood pressure, and SpO2; MobiMed ePR, an electronic system for documenting treatments and events; and MobiMed Life, which is engineered for advanced patient monitoring and resuscitation. They also offer MobiMed Cloud, a platform enabling data sharing across various operating systems such as Windows, web, iOS, and Android. In addition to these products, Ortivus provides a range of services including support, implementation assistance, training, and consulting.
Market snapshot
- Symbol
- ORTI-B.ST
- Price
- $1.84
- Day change
- +0.55%
- Market cap
- $81.3M
- P/E ratio
- -4.85x
- 52-week range
- 0.802-2.14
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
Peer companies
- AcouSort AB (publ) (ACOU.ST)
- Aino Health AB (publ) (AINO.ST)
- ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)
- Scandinavian Real Heart AB (Publ) (HEART.ST)
- Lipigon Pharmaceuticals AB (publ) (LPGO.ST)
- Modus Therapeutics Holding AB (publ) (MODTX.ST)
- Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)
- OncoZenge AB (publ) (ONCOZ.ST)
Open Ortivus AB (publ) (ORTI-B.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.